Prognosis of patients with Hodgkin lymphoma and indeterminate response to PD-1 inhibitor therapy: considerations for application of LYRIC criteria in real clinical practice

Related articles

1. Measurable residual disease assessment in apheresis product from multiple myeloma patients: association with biology, depth of response and survival.

   This article has 25 authors:

   1. Noemí Puig
   2. Borja Puertas
   3. Irene Padilla
   4. Elena Alejo
   5. Fe Serra-Toral
   6. Aránzazu García-Mateo
   7. Rosa Lopez-Lopez
   8. Abelardo Baréz
   9. Jose María Alonso Alonso
   10. Carlos Aguilar-Franco
   11. Erik de Cabo
   12. Alberto Cantalapiedra-Diez
   13. Alfonso García de Coca
   14. Roberto Hernandez
   15. Beatriz Rey-Bua
   16. MARTA FONSECA-SANTOS
   17. MIRIAM LÓPEZ-PARRA
   18. Lucía López-Corral
   19. Norma Gutierrez
   20. Maria-Belén Vidriales
   21. Jose J Perez
   22. Verónica González-Calle
   23. Maria Victoria Mateos Manteca
   24. Fernando Escalante
   25. Juan Flores-Montero

2. Evaluating Limited-Duration DRd Treatment in Biochemical and Clinical Relapse of Multiple Myeloma: A Taiwan-Based Analysis

   This article has 6 authors:

   1. Lingjung Chiu
   2. Ming-Chung Wang
   3. Ming-Chun Ma
   4. Hung-Lin Liu
   5. Bi-Han Liao
   6. Ching-yuan Kuo

3. Prognostic value of the αPRTA scoring system in unresectable hepatocellular carcinoma treated with TACE, Lenvatinib, and anti-PD-1 antibodies: a multicenter retrospective study

   This article has 7 authors:

   1. Yu Zhou
   2. Liya Suo
   3. Yuchen Zhou
   4. Zaixing Wang
   5. Wanying Qin
   6. Xudong Fei
   7. Jiangfan Wu